Stocks Comparison
Natural Alternatives International vs Tilray Brands: revenue, profit, margins and growth compared
Natural Alternatives International brought in $129.9M of revenue in fiscal 2025, Tilray Brands $915.5M in fiscal 2026. Revenue changed by +14.1% at Natural Alternatives International and +11.5% at Tilray Brands on the year before, so Natural Alternatives International grew faster. Natural Alternatives International kept -10.5% of its revenue as net profit, Tilray Brands -13.3%.
Side by side, latest fiscal year
| NAII | TLRY | |
|---|---|---|
| Fiscal year ended | FY2025 (June 30, 2025) | FY2026 (May 31, 2026) |
| Revenue | $129.9M | $915.5M |
| Revenue growth | +14.1% | +11.5% |
| Net income | -$13.6M | -$121.4M |
| Net margin | -10.5% | -13.3% |
| Free cash flow | $2.3M | n/a |
| Free cash flow margin | 1.8% | n/a |
| Earnings per share (diluted) | -$2.28 | -$1.09 |
| Cash | $12.3M | $226M |
| Debt | n/a | n/a |
| Price to earnings | n/a | n/a |
| Market value | $11M | $481.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #286 of 646 · Health care | #152 of 646 · Health care |
Over the years
Questions about Natural Alternatives International and Tilray Brands
Which is bigger by revenue, Natural Alternatives International or Tilray Brands?
Tilray Brands is bigger by revenue: $915.5M in fiscal 2026, against $129.9M for Natural Alternatives International in fiscal 2025.
Which keeps more of its revenue as profit, Natural Alternatives International or Tilray Brands?
Natural Alternatives International had a net margin of -10.5% in fiscal 2025; Tilray Brands had -13.3% in fiscal 2026.
Which grew revenue faster, Natural Alternatives International or Tilray Brands?
In their latest fiscal years revenue changed by +14.1% at Natural Alternatives International and +11.5% at Tilray Brands.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.